This site is intended for healthcare professionals only
LoginRegister
Cancer MedTech Gets Clarity: CDSCO Releases Final Oncology Device Risk Classification ListSEC Clears Hemopurifier Device for Cancer Study in Indian Patients
Intas appoints Ex-Dr Reddys executive Rambabu Ogirala as Associate Vice President - Manufacturing FinanceIntas appoints Ex-Dr Reddy's executive Rambabu Ogirala as Associate Vice President - Manufacturing...
Lupin rolls out constipation drug Prucalopride in US after USFDA nodLupin rolls out constipation drug Prucalopride in US after USFDA nod
Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boomUSFDA greenlights label update for Eli Lilly Amyvid to support Alzheimer's disease diagnosis in...
Sanofi Gets CDSCO Panel Nod to Update Prescribing Information for XenpozymeUSFDA grants orphan drug designation to Sanofi Riliprubart for AMR in solid organ transplantation
Advent to Sell Zentiva to Private Equity GTCR in USD 4.8 Billion Deal, Closing Expected in 2026Novartis concludes acquisition of Regulus Therapeutics
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosusAstraZeneca-Daiichi Sankyo Datroway gets USFDA accelerated nod for previously treated advanced...
Eli lilly, Circle Pharma ink pact to further enhance AI/ML capabilitiesGilead Sciences, Kymera Therapeutics ink pact to develop novel oral molecular glue CDK2 degraders
GPAT 2025 Results OUT.GPAT 2025 Results OUT, Scorecards Available from July 4
Around 5,000 Small Pharma Units at Risk as Centre Enforces Tougher GMP NormsSMS Pharma successfully completes USFDA inspection at Telangana Central Laboratory Analytical...
India imposes anti-dumping duty on six Chinese productsIndia tightens grip on Chinese imports with anti dumping duty on six products
Health Ministry Reduces Clinical Trial Approval Time from 90 to 45 Days58 Unauthorised Clinical Trials Spark DCGI Ban on VS Hospital, Doctors, Pharma Giants Under Fire
X